HUGE!
- Forums
- ASX - By Stock
- DXB
- Ann: FDA confirms Proteinuria as Primary Endpoint for US approval
DXB
dimerix limited
Add to My Watchlist
1.06%
!
47.5¢

Ann: FDA confirms Proteinuria as Primary Endpoint for US approval, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
47.5¢ |
Change
0.005(1.06%) |
Mkt cap ! $283.5M |
Open | High | Low | Value | Volume |
47.5¢ | 48.5¢ | 47.0¢ | $394.0K | 828.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 42005 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 252168 | 0.470 |
15 | 129325 | 0.465 |
22 | 435522 | 0.460 |
12 | 153622 | 0.455 |
13 | 267641 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 48188 | 7 |
0.485 | 96696 | 6 |
0.490 | 58230 | 5 |
0.495 | 6445 | 1 |
0.500 | 12421 | 2 |
Last trade - 14.23pm 01/08/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online